Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015, GRIDX is a venture studio based in Buenos Aires, Argentina, dedicated to the bioeconomy. The organization focuses on transforming bioscience knowledge and talent in Latin America into startups with global impact. GRIDX operates as a company builder, emphasizing the convergence of biology, digital tools, and advanced engineering to create innovative companies.
Currently, GRIDX manages a fund size of $30 million and has built a portfolio of 81 companies. The organization employs nearly 700 people, with a significant portion based in Latin America. GRIDX has established itself as a leading platform in the bioeconomy, backed by notable figures such as Marcos Galperin, founder of MercadoLibre, and Hugo Sigman, a prominent pharmaceutical entrepreneur.
GRIDX's mission is to harness the rich bioscience knowledge in Latin America to create startups that contribute to human and planetary health. The firm operates across seven Latin American countries, including Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Uruguay.
GRIDX invests primarily in sectors related to healthcare, agriculture, bioindustry, and materials. Their investment strategy emphasizes life-compatible production systems that promote human and planetary health. The firm targets startups innovating in agri-food, bioindustry, human health, and deep biotech, with a strong focus on the Latin American region.
Investment stages include Seed and Series A, with check sizes ranging from $200,000 to $1.5 million. GRIDX seeks to partner with founders who are committed to scientific innovation and have a clear vision for their startups. The firm prefers to engage in hands-on support, helping startups navigate the complexities of the biotech landscape.
GRIDX's portfolio includes a diverse range of companies that reflect its commitment to advancing the bioeconomy. Notable portfolio companies include:
These companies exemplify GRIDX's focus on sectors such as biotech, healthcare, agtech, and food-agtech, showcasing the potential for innovation in the Latin American market.
Matías Peire - General Partner & Founder. Matías has a background in biotechnology and has led several successful ventures in the sector.
María Renner - General Partner. María brings extensive experience in venture capital and has a strong focus on healthcare investments.
Federico Marque - General Partner. Federico specializes in agtech and has a proven track record of supporting startups in this field.
Romina Casadevall - Partner, Argentina. Romina has expertise in biotech and plays a key role in sourcing new investment opportunities.
Francisco Salvatelli - Partner, Brazil. Francisco focuses on expanding GRIDX's presence in Brazil and has a strong network in the local startup ecosystem.
Teresa de León - Country Manager, Mexico. Teresa oversees operations in Mexico and has a background in life sciences.
Dandara Porto Pedreira - Scientific Explorer, Brazil. Dandara is responsible for identifying scientific innovations that can be transformed into startups.
Ana Paula Acevedo - Scientific Explorer, Mexico. Ana Paula focuses on the Mexican biotech landscape and supports local entrepreneurs.
Nicole Elenter - Scientific Explorer, Uruguay. Nicole identifies opportunities in Uruguay's biotech sector and collaborates with local researchers.
Juan Pablo Orlov - Associate, Uruguay. Juan Pablo supports the investment team in evaluating potential startups.
Mariela Cherñacov - Business Administrator. Mariela manages the administrative functions of GRIDX.
Juan Boucau - Portfolio Development Support. Juan assists portfolio companies in their growth strategies.
Victoria Chiyah - Financial Advisor. Victoria provides financial guidance to GRIDX and its portfolio companies.
Julia Rozas - Communications Scientific Leader. Julia oversees communication strategies for GRIDX.
Guadalupe Moro - Graphic & Experience Designer. Guadalupe enhances the visual identity of GRIDX and its portfolio companies.
To pitch to GRIDX, founders should use the preferred channel available on their website at gridexponential.com. It is essential to include a comprehensive deck that outlines the business model, team, and technology. GRIDX appreciates detailed information about the startup's potential impact on the bioeconomy.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are beneficial, as they can facilitate the initial connection with the investment team.
GRIDX runs a program called GRIDX, which focuses on building startups in the bioeconomy. This program supports entrepreneurs in transforming scientific research into viable business models. Eligibility criteria typically include a strong scientific foundation and a commitment to innovation in the biotech sector.
To apply for the GRIDX program, interested founders can visit the GRIDX website for more information on the application process and requirements.
In mid-2025, GRIDX closed its second fund with a size of $30 million, aimed at supporting deeptech ventures in Latin America. The firm has expanded its portfolio significantly, growing from 56 to 81 companies, reflecting its active engagement in the biotech sector.
Recent investments include notable companies such as Stämm, Puna Bio, and CASPR, which align with GRIDX's mission to advance the bioeconomy. The firm continues to be recognized as a leading platform in the Latin American bioeconomy, backed by prominent investors like Marcos Galperin and Hugo Sigman.
What are GRIDX's investment criteria?
GRIDX invests in startups within the biotech, healthcare, agtech, and food-agtech sectors. They focus on companies at the Seed and Series A stages, with check sizes ranging from $200,000 to $1.5 million.
How can I apply or pitch to GRIDX?
Founders can pitch their startups through the GRIDX website at gridexponential.com. It is recommended to include a detailed business plan and information about the team and technology.
What makes GRIDX different from other investors?
GRIDX operates as a venture studio, providing hands-on support to transform scientific research into viable startups. Their model emphasizes collaboration and resource sharing among portfolio companies.
What is GRIDX's geographic scope?
GRIDX primarily invests in Latin America, focusing on countries such as Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Uruguay.
What is GRIDX's post-investment involvement like?
GRIDX is known for its active involvement in the growth of its portfolio companies, offering operational support, mentorship, and access to a network of experts in the biotech field.
What is the size of GRIDX's fund?
GRIDX currently manages a fund size of $30 million, which supports its investments in the bioeconomy sector.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.